|
1
|
Dorweiler B, Pruefer D, Andrasi TB, Maksan
SM, Schmiedt W, Neufang A and Vahl CF: Ischemia-reperfusion injury:
Pathophysiology and clinical implications. Eur J Trauma Emerg Surg.
33:600–612. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eckle T: New ‘Guidance’ for the treatment
of hepatic ischemia reperfusion injury through semaphorins and
plexins. Crit Care Med. 44:1623–1624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu H, Chen G, Wyburn KR, Yin J, Bertolino
P, Eris JM, Alexander SI, Sharland AF and Chadban SJ: TLR4
activation mediates kidney ischemia/reperfusion injury. J Clin
Invest. 117:2847–2859. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung SJ, Li L, Huang L, Lawler J, Ye H,
Rosin DL, Vincent IS, Le TH, Yu J, Görldt N, et al: Proximal tubule
CD73 is critical in renal ischemia-reperfusion injury protection. J
Am Soc Nephrol. 28:888–902. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nezu M, Souma T, Yu L, Suzuki T, Saigusa
D, Ito S, Suzuki N and Yamamoto M: Transcription factor Nrf2
hyperactivation in early-phase renal ischemia-reperfusion injury
prevents tubular damage progression. Kidney Int. 91:387–401. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zou K, Li Z, Zhang Y, Zhang HY, Li B, Zhu
WL, Shi JY, Jia Q and Li YM: Advances in the study of berberine and
its derivatives: A focus on anti-inflammatory and anti-tumor
effects in the digestive system. Acta Pharmacol Sin. 38:157–167.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li D, Zheng J, Hu Y, Hou H, Hao S, Liu N
and Wang Y: Amelioration of intestinal barrier dysfunction by
berberine in the treatment of nonalcoholic fatty liver disease in
rats. Pharmacogn Mag. 13:677–682. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haufe TC, Gilley AD, Goodrich KM, Ryan CM,
Smithson AT, Hulver MW, Liu D and Neilson AP: Grape powder
attenuates the negative effects of GLP-1 receptor antagonism by
exendin-3 (9–39) in a normoglycemic mouse model. Food Funct.
7:2692–2705. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhao GL, Yu LM, Gao WL, Duan WX, Jiang B,
Liu XD, Zhang B, Liu ZH, Zhai ME, Jin ZX, et al: Berberine protects
rat heart from ischemia/reperfusion injury via activating
JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress.
Acta Pharmacol Sin. 37:354–367. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koo TY, Lee JG, Yan JJ, Jang JY, Ju KD,
Han M, Oh KH, Ahn C and Yang J: The P2X7 receptor antagonist,
oxidized adenosine triphosphate, ameliorates renal
ischemia-reperfusion injury by expansion of regulatory T cells.
Kidney Int. 92:415–431. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Linkermann A, Bräsen JH, Darding M, Jin
MK, Sanz AB, Heller JO, De Zen F, Weinlich R, Ortiz A, Walczak H,
et al: Two independent pathways of regulated necrosis mediate
ischemia-reperfusion injury. Proc Natl Acad Sci USA.
110:12024–12029. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thorenz A, Chen R, Rong S, Klemann C,
Haller H, Braesen JH, Klos A and Gueler F: C5aR2 deficiency
improves renal regeneration after renal ischemia reperfusion injury
and in kidney transplantation in mice. FASEB J. 31:1030.9.
2017.
|
|
13
|
Nogueira MA, Coelho AM, Sampietre SN,
Patzina RA, da Silva Pinheiro F, D'Albuquerque LA and Machado MC:
Beneficial effects of adenosine triphosphate-sensitive
K+ channel opener on liver ischemia/reperfusion injury.
World J Gastroenterol. 20:15319–15326. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Noh MR, Kim JI, Han SJ, Lee TJ and Park
KM: C/EBP homologousprotein (CHOP) gene deficiency attenuates renal
ischemia/reperfusioninjury in mice. Biochim Biophys Acta.
1852:1895–1901. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lau A, Wang S, Liu W, Haig A, Zhang ZX and
Jevnikar AM: Glycyrrhizic acid ameliorates HMGB1-mediated cell
death and inflammation after renal ischemia reperfusion injury. Am
J Nephrol. 40:84–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin M, Li L, Li L, Pokhrel G, Qi G, Rong R
and Zhu T: The protective effect of baicalin against renal
ischemia-reperfusion injury through inhibition of inflammation and
apoptosis. BMC Complement Altern Med. 14:192014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Edlich F and Martinou JC: Bcl-2 protein
interplay on the outer mitochondrial membraneMitochondria and Cell
Death. Springer; New York: pp. 69–83. 2016, View Article : Google Scholar
|
|
18
|
Liu Y, Wang L, Du Y, Chen Z, Guo J, Weng
X, Wang X, Wang M, Chen D and Liu X: Effects of apigenin
pretreatment against renal ischemia/reperfusion injury via
activation of the JAK2/STAT3 pathway. Biomed Pharmacother.
95:1799–1808. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schrezenmeier EV, Barasch J, Budde K,
Westhoff T and Schmidt-Ott KM: Biomarkers in acute kidney injury -
pathophysiological basis and clinical performance. Acta Physiol
(Oxf). 219:554–572. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chatterjee PK, Brown PA, Cuzzocrea S,
Zacharowski K, Stewart KN, Mota-Filipe H, McDonald MC and
Thiemermann C: Calpain inhibitor-1 reduces renal
ischemia/reperfusion injury in the rat. Kidney Int. 59:2073–2083.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shen S and Zhou J, Meng S, Wu J, Ma J, Zhu
C, Deng G, Liu D, Shen S and Zhou J: The protective effects of
ischemic preconditioning on rats with renal ischemia-reperfusion
injury and the effects on the expression of Bcl-2 and Bax. Exp Ther
Med. 14:4077–4082. 2017.PubMed/NCBI
|
|
22
|
Decuypere JP, Ceulemans LJ, Agostinis P,
Monbaliu D, Naesens M, Pirenne J and Jochmans I: Autophagy and the
kidney: Implications for ischemia-reperfusion injury and therapy.
Am J Kidney Dis. 66:699–709. 2015. View Article : Google Scholar : PubMed/NCBI
|
